A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis

NCT00676156 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: oral lipoic acid (LA)
DRUG: lipoic acid (LA) with fish oil and LA without fish oil
DRUG: R lipoic acid

Sponsor

Oregon Health and Science University

Collaborators

[object Object]